M
Maura Marcucci
Researcher at McMaster University
Publications - 156
Citations - 6781
Maura Marcucci is an academic researcher from McMaster University. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 35, co-authored 136 publications receiving 5262 citations. Previous affiliations of Maura Marcucci include St. Joseph's Healthcare Hamilton & University of Milan.
Papers
More filters
Journal ArticleDOI
Drug treatments for covid-19: living systematic review and network meta-analysis.
Reed A C Siemieniuk,Jessica J Bartoszko,Long Ge,Dena Zeraatkar,Ariel Izcovich,Elena Kum,Hector Pardo-Hernandez,Anila Qasim,Juan Pablo Diaz Martinez,Bram Rochwerg,Francois Lamontagne,Mi Ah Han,Qin Liu,Arnav Agarwal,Arnav Agarwal,Thomas Agoritsas,Derek K. Chu,Rachel Couban,Ellen Cusano,Andrea Darzi,Tahira Devji,Bo Fang,Carmen Fang,Signe Flottorp,Signe Flottorp,Farid Foroutan,Farid Foroutan,Maryam Ghadimi,Diane Heels-Ansdell,Kimia Honarmand,Liangying Hou,Xiaorong Hou,Quazi Ibrahim,Assem M. Khamis,Bonnie Lam,Mark Loeb,Maura Marcucci,Shelley McLeod,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,Reem A. Mustafa,John Neary,Gabriel Rada,Irbaz Bin Riaz,Behnam Sadeghirad,Nigar Sekercioglu,Lulu Sheng,Ashwini Sreekanta,Charlotte Switzer,Britta Tendal,Lehana Thabane,George Tomlinson,Tari Turner,Per Olav Vandvik,Robin W.M. Vernooij,Andrés Viteri-García,Ying Wang,Liang Yao,Zhikang Ye,Gordon H Guyatt,Romina Brignardello-Petersen +61 more
TL;DR: Glucocorticoids probably reduce mortality and mechanical ventilation in patients with covid-19 compared with standard care and the effectiveness of most interventions is uncertain because most of the randomised controlled trials so far have been small and have important study limitations.
Journal ArticleDOI
A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
Lehana Thabane,Lawrence Mbuagbaw,Lawrence Mbuagbaw,Shiyuan Zhang,Shiyuan Zhang,Zainab Samaan,Maura Marcucci,Maura Marcucci,Chenglin Ye,Chenglin Ye,Marroon Thabane,Lora Giangregorio,Brittany B. Dennis,Brittany B. Dennis,Daisy Kosa,Daisy Kosa,Daisy Kosa,Victoria Borg Debono,Victoria Borg Debono,Rejane Dillenburg,Vincent Fruci,Monica Bawor,Juneyoung Lee,George A. Wells,Charles H. Goldsmith,Charles H. Goldsmith,Charles H. Goldsmith +26 more
TL;DR: When reporting on a clinical trial, it is recommended to include planned or posthoc sensitivity analyses, the corresponding rationale and results along with the discussion of the consequences of these analyses on the overall findings of the study.
Journal ArticleDOI
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
A. Tosetto,Alfonso Iorio,Maura Marcucci,Trevor Baglin,Mary Cushman,Sabine Eichinger,Gualtiero Palareti,Daniela Poli,Rc Tait,James D. Douketis +9 more
TL;DR: This data indicates that in patients with unprovoked venous thromboembolism, the optimal duration of anticoagulation is anchored on estimating the risk of disease recurrence, and this work contributes to this understanding.
Journal ArticleDOI
Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor: A Systematic Review
Alfonso Iorio,Clive Kearon,Esmeralda Filippucci,Maura Marcucci,Ana Macura,Vittorio Pengo,Sergio Siragusa,Gualtiero Palareti +7 more
TL;DR: The risk of recurrence is low if VTE is provoked by surgery, intermediate if provoked by a nonsurgical risk factor, and high if unprovoked, which affects whether patients with VTE should undergo short-term vs indefinite treatment.
Journal ArticleDOI
Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review.
João Apóstolo,Richard Cooke,Elzbieta Bobrowicz-Campos,Silvina Santana,Maura Marcucci,Antonio Cano,Miriam Marie Rosé Vollenbroek-Hutten,Federico Germini,Barbara D'Avanzo,Holly Gwyther,Carol Holland +10 more
TL;DR: There is mixed results regarding the effectiveness of frailty interventions, but there is clear evidence on the usefulness of such interventions in carefully chosen evidence-based circumstances, both for frailty itself and for secondary outcomes, supporting clinical investment of resources in frailty intervention.